Key takeaway [for me] so far from this morning’s panel on how to balance patient-centric #digitaltherapeutics with scalable profitability can be summarised by the phrase “Build and they will come”. If you build a product that is intrinsically engaging and keeps patient adherent to the programme, then the clinical outcomes will show themselves, product value can be seen, and uptake will come and with it the money. And how to make a product engaging? For Hannes Klöpper of HelloBetter , it’s about getting patients involved as much as possible in the product development, get their feedback, use it to make necessary tweaks to improve the technology . No brainer? Are DTx companies already doing this? Other insights from Marek Ostrowski of Prosoma Kamran Adle Christian Lautner LSX - partnering for Life Science eXecutives #lsxworldcongress Laura Wamprecht
Tina Tan’s Post
More Relevant Posts
-
When we look at where successful innovation exists, we find it at the intersection of desirability, feasibility, and viability. Last month, Brandon Bogdalek led a panel discussion with Nancy Schoenbrunner, Tom W. Burke, and Michael Hill - three leading experts in the MedTech space. Among the topics discussed was the importance of understanding user needs as a vital input for successful innovation. The panel unanimously agreed; we are most successful when we truly understand people - their hopes, fears, and needs. Our culture at Veranex is rooted in human-centered design and innovation. It's leaders like Michael Hill and many others in our industry who inspire us to empower the experts, and work to advance medical care and improve patient lives. #medtech #diagnostics #patientexperience #innovation #humancentereddesign
Understanding the Importance of User Needs
To view or add a comment, sign in
-
Join us in welcoming One2Treat, our innovative, patient-centric startup set to transform the way treatments are evaluated in a more holistic way in both clinical research and market access. 🎉 One2Treat's unique value proposition emerges in its ability to integrate all key patient-relevant outcomes into a single comprehensive assessment of treatment effects. This leads to significantly reduced trial sample sizes and expedited market access to innovative treatments – treatments that will better meet the multi-facet needs of patients! 🌟 Together, let’s move on this transformative journey as we aim to accelerate patients’ access to groundbreaking treatments. Discover more about our mission and the impact we aspire to make by reading our Press Release. 🚀 https://lnkd.in/esHsm_Kt #PatientCentricity #HealthcareInnovation #ClinicalResearch #ReduceTimeToMarket
To view or add a comment, sign in
-
Breaking the barriers to innovation, expert insights from #SurgTech2024 At the recent SurgTech 2024 conference, Kevin Kiely, a prominent figure in the Health Tech industry, shed light on a critical barrier in innovation – stringent regulations and the lack of capacity within approving bodies. While regulations are necessary to ensure patient safety and efficacy, the current process can be lengthy, complex, and lacking in resources, posing significant challenges for startups and innovators, especially those with limited regulatory expertise. However, here are some insights on how companies can navigate this obstacle. -Instead of viewing regulations as roadblocks, innovators should embrace a mindset of compliance from the outset. Involving regulatory experts early on, preferably during the product development phase, can help align solutions with existing guidelines and streamline the approval process. -The regulatory landscape is constantly evolving, and companies must be agile and adaptable. Staying up-to-date with the latest regulatory developments and being willing to adjust strategies accordingly is crucial for success. If you’d like to understand more about how to be more receptive to change and how we can help, then dive into this video we’ve created https://lnkd.in/efJw6RPk With a culture of compliance, expert guidance, strategic alliances, and a willingness to adapt, Health Tech companies can turn regulatory challenges into opportunities for growth and success. What has been your experience in navigating regulatory hurdles? Share your insights and strategies in the comments below. #adaptability #commercialisation #design #problemsolving #regulations #innovation #insights #barrier #navigatingregulations #strategy #experts ABHI Medilink North of England Bionow SBRI Healthcare Varaidzo (Vee) Mapunde Andrew Davidson Rich Shaw NIHR for Industry Neville Young Dave Holmes
To view or add a comment, sign in
-
🚀 To kick off the new year, we’re thrilled to share our CEO Karim Aly's latest interview in Mergermarket with Deborah Balshem! In this interview, Karim discusses Noze’s groundbreaking plans for using its digital odor perception technology in the early diagnostics space. He also talks about our big plans for this year, including raising our Series B funding round and continuing to run clinical studies across multiple medical conditions. Watch this space for more on Noze’s exciting journey in 2024! Read the full article below! #DigitalOlfaction #Healthcare #Technology #EarlyDiagnostics
To view or add a comment, sign in
-
Elevate research strategy with MedPro Insights' revolutionary methodologies! 🚀 Expertise in quantitative and qualitative research empowers uncovering new perspectives and driving informed decision-making in healthcare. 💡 Leveraging innovative solutions gains a competitive edge, transforming data into actionable insights and impactful outcomes. 🌟 A dedicated team ensures research objectives are met with precision and reliability, setting the stage for transformative results and strategic success. 🔍 Partnering with MedPro Insights redefines research excellence, driving meaningful impact and leading the way in healthcare innovation! Let's embark on the path to success together: 📞: +1(866)747-7340 📩: hello@medproinsights.com 🌐: https://lnkd.in/gcdng-TK #effectiveness #successfulprojects #projectexecution #teamwork #organizationalgoals #streamlinedprocess #projectsuccess #globalteams #geographicalboundaries
To view or add a comment, sign in
-
If you're prepping a Series A pitch, there are five things you must have in play: 1. A strong founding team with a clear vision and the ability to execute. 2. An innovative product/service with the potential to disrupt the market OR seamlessly integrate into an industry's ecosystem. 3. A large, addressable market that offers significant growth opportunities. 4. Early traction and positive feedback indicating product-market fit. 5. The potential for rapid growth and scalability of the business model. When I joined 98point6 it was just after they landed their Series A round. My CPO shared with me a video demo of a virtual visit between a bot and a patient—vision for an autonomous primary care visit from intake through diagnosis and treatment. With only a low-fidelity clinical trial in the market that served one patient per day, it was this particular manifestation of our product vision—how our business would impact the primary care market—that helped sell our early investors on the promise of the business. And while we later developed more specific north star collateral around a brand narrative, one could argue that this single demo laid the groundwork for our core investments over the next 2.5 years: > We scaled teams across the organization to reach compliance, security, and clinician licensing requirements—all based on how we'd empower PCPs to service patients across 50 states. > We designed deep technology approaches to progressively automate more and more of the patient journey and how clinicians received data to run their differential diagnosis. > We designed a product experience that brought consumer polish to features centered around patient, clinician, and buyer needs. Moral of the story: A clearly elucidated vision for how a business will bring innovation to life while changing the game within a particular ecosystem IS the product before there is a product in play.
To view or add a comment, sign in
-
Embracing new technologies is crucial to offer significant advances representing a paradigm shift in drug discovery, clinical trial site optimization, and patient engagement. Leveraging Cybage's articulated strategy and tech expertise for intelligent trial intervention will set life sciences firms on the right path. Know more: https://hubs.li/Q01YzhV20 #Healthcare #LifeSciences #DigitalHealth
To view or add a comment, sign in
-
Medable, Inc has been working so hard on addressing the challenges faced when running a clinical trial; A big one of which is study start. Often, the digital platform can be a rate limiter in how fast you can take your trial live. Being able to not only reduce this down to 8 weeks, taking it off the critical path... but doing so by leveraging the power of our platform, mean this is now a truly scaleable solution that drives quality is HUGE! Take a look at the post below for more info 😁 #clinicaltrials #clinicalresearch #ecoa #clinicaldevelopment
Announcement 🆕: We're thrilled to offer new intelligent automation technology, applied throughout our clinical trials platform, that cuts standard trial build timelines by at least 50%. Early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking. By automating laborious, manual tasks such as testing, Medable, Inc saves substantial time and removes eCOA from the critical path to trial go-live. Learn more here ➡️: https://lnkd.in/eWmEkC-W ________ Michelle Longmire, Tim Smith, Alison Holland, Jason Rothbart, Hady Khoury, Amar Jani, Colin Weller #clinicaltrials #clinicalresearch #healthcare #eCOA #clinicaldevelopment
To view or add a comment, sign in
-
Dani highlights the transformative potential of patient co-design in #ClinicalTrials. By leveraging mini-communities, we can enhance #PatientEngagement and trial design, paving the way for improved recruitment and retention rates. The continuous insights gained from patients can significantly boost overall trial success. Embracing this innovative approach could revolutionize your team's strategy and positively impact your product lifecycle. 🔗 Read the full article here: https://buff.ly/3IuD8nQ Join the conversation and let us know your thoughts in the comments! #MiniCommunities #Innovation #HumanElement
To view or add a comment, sign in
Digital Health | Evidence Generation | Research Strategy | People Leader | Science Communicator | Behavioral Science | Recovered Academic
2moIf DTx companies are doing this, they mostly aren’t talking about it… but I suspect most are not listening to the user/patients enough. We’ve seen research and science budgets get slashed with budget cuts and layoffs, along with UX researchers - but these are going to be critical to improving engagement, which is the KPI we should all be chasing.